KIR3DL1 and acute myeloid leukemia: More broadly, a specific donor KIR B gene content score that is ≥2 [143], donor KIR B genotypes [144], or donor KIR CenB02 [145] should be favored for AML patients in order to decrease relapse incidence, which suggests that there is a need to detect the activating KIR genes.